Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Neurobiol Dis. 2020 Jan 21;137:104754. doi: 10.1016/j.nbd.2020.104754

Table 2:

Metabolic data of light-deprived mice in a type 1 diabetes model.

12 hr ON: 12 hr OFF (Control) 24 hr OFF (Light-Deprived)

Non-diabetic Vehicle Diabetic Streptozotocin Non-diabetic Vehicle Diabetic Streptozotocin
n 11 8 12 9
Body Weight, g, 2 months (Pre-Injection) 22.4 (1.3) 19.9 (0.7) 21.2 (0.8) 20.7 (0.7)
Body Weight, g, 4 months (at randomization) 24.9 (1.4) 21.4 (0.2)* 24.1 (0.6) 21.6 (0.5)
Body Weight, g, 6 months (at assay) 25.3 (1.3) 22.3 (0.3) 24.8 (0.5) 22.7 (0.6)
Random Plasma Glucose, mg/dL, 2 months (Pre-Injection) 127.0 (3.5) 149.3 (33.1) 139.4 (25.9) 118.5 (10.5)
Random Glucose (mg/dL), 4 months (at randomization) 152.2 (10.3) 550.5 (29.0)**** 159.0 (6.1) 521.3 (18.9)****
Random Glucose (mg/dL), 6 months (at assay) 156.9 (15.9) 525.0 (15.6)**** 146.4 (13.0) 545.1 (12.3)****

Measures were taken at the time of diabetes induction, at time of randomization to control lighting or light-deprivation, and at the time of assay. Data are represented as mean (SEM) and groups were compared by 1-way (for GTT AUC and Fasting Insulin) or 2-way (for body weight and glucose) ANOVA with Bonferroni post-hoc correction.

*

= P<0.05

****

= P<0.0001 compared to healthy controls within same lighting group; P>0.05 for all other comparisons.